In JIA-specific preclinical models (such as collagen-induced arthritis), this multi-target approach has been demonstrated to be effective, primarily by modulating inflammatory pathways like NLRP3/NF-κB (77). This evidence concerns the gene NFKB1 and juvenile idiopathic arthritis.